市场调查报告书
商品编码
1395088
褪黑激素产品市场规模 - 按类型(天然褪黑激素、合成褪黑激素)按应用(医疗、膳食补充剂)按形式(丸剂、咀嚼片、液体、喷雾剂)、按分销(药房、线上零售)与全球预测,2023-2032 年Melatonin Products Market Size - By Type (Natural melatonin, Synthetic melatonin) By Application (Medical, Dietary supplements) By Form (Pills, Chewable, Liquid, Sprays), By Distribution (Pharmacies, Online retail), & Global Forecast, 2023-2032 |
由于全球睡眠障碍盛行率不断上升,预计 2023 年至 2032 年褪黑激素产品市场规模将以超过 14.3% 的CAGR扩大。
失眠、睡眠呼吸中止症和昼夜节律紊乱等睡眠状况的激增推动了对几种自然疗法的需求。此外,压力水平的上升、工作时间的延长以及电子设备的普遍使用都导致睡眠模式被破坏,进一步促使人们寻求有效的解决方案。产业参与者越来越关注满足对有效的褪黑激素注入解决方案不断增长的需求,以解决与睡眠相关的问题,这将增强产业前景。例如,2023年11月,PharmaLinea推出了基于褪黑激素及其专利成分Qnight的新型临床保证膳食补充剂,以帮助改善睡眠品质和急性睡眠潜伏期。
褪黑激素产品产业分为类型、应用、形式、配销通路和地区。
根据类型,由于消费者对天然助眠剂的偏好不断增加,预计天然褪黑激素产品市场从 2023 年到 2032 年的CAGR将超过 12%。源自植物(例如酸樱桃)的天然褪黑激素补充剂因其公认的健康益处和最小的副作用而受到关注。此外,越来越多的消费者寻求非合成替代品来支持睡眠,这将推动对天然褪黑激素产品的需求。
就应用而言,到2032年,医疗领域褪黑素产品市场的成长率可能会超过14%。这可以归因于褪黑素的治疗潜力越来越多地被使用。此外,褪黑激素的神经保护和抗氧化特性也有助于其在治疗某些医疗状况中的越来越多的应用。此外,正在进行的研发活动旨在发现褪黑激素的多种医疗功效,这将促进该领域的成长。
从地区来看,随着睡眠相关问题在该地区日益普遍,亚太地区褪黑激素产品市场预计在 2023 年至 2032 年间以 13.6% 的成长率扩张。中国、印度和日本等国家对褪黑激素产品的需求正在激增,以满足寻求传统睡眠辅助品替代品的注重健康的消费者的需求。
此外,对褪黑素饮料、补充剂和美容产品等多种配方的需求不断增长,为行业参与者提供了潜在的成长机会,从而加速了区域产业的扩张。例如,2022年12月,澳洲保健食品公司梅尔罗斯健康集团宣布计画以新的市场策略和新的产品线拓展中国市场,其中包括推出结合玻尿酸、褪黑素和虾红素的美容睡眠产品。
Melatonin Products Market size is projected to expand at over 14.3% CAGR from 2023-2032 due to the rising prevalence of sleep disorders globally.
The surge in sleep conditions, such as insomnia, sleep apnea, and circadian rhythm disruptions is propelling the demand for several natural remedies. Additionally, the rising stress levels, longer working hours, and the pervasive usage of electronic devices are contributing to disrupted sleep patterns, further leading individuals to seek effective solutions. The growing focus of industry participants on catering to the rising demand for effective melatonin-infused solutions to address the sleep-related issues will augment the industry outlook. For instance, in November 2023, PharmaLinea launched a new clinically guaranteed dietary supplement based on melatonin and its patented component, Qnight to help with sleep quality and acute sleep latency.
The melatonin products industry is segmented into type, application, form, distribution channel, and region.
Based on type, the natural melatonin products market is anticipated to observe over 12% CAGR from 2023-2032 owing to the increasing consumer preference for natural sleep aids. Natural melatonin supplements sourced from plants, such as tart cherries are gaining prominence due to their perceived health benefits and minimal side effects. Furthermore, the rising number of consumers seeking non-synthetic alternatives for sleep support will push the demand for natural melatonin products.
With respect to application, the melatonin products market from the medical segment is likely to record over 14% growth rate through 2032. This can be attributed to the increasing use of melatonin for its therapeutic potential. Additionally, the neuroprotective and antioxidant properties of melatonin are contributing to its increasing use in managing certain medical conditions. Moreover, the ongoing R&D initiatives to discover the diverse medical benefits of melatonin will boost the segment growth.
Regionally, the Asia Pacific melatonin products market is poised to expand at 13.6% growth rate between 2023 and 2032 with sleep-related issues becoming increasingly prevalent across the region. Countries like China, India, and Japan are experiencing surging demand for melatonin products to cater to health-conscious consumers seeking alternatives to traditional sleep aids.
Furthermore, the surging need for diverse formulations, such as melatonin-infused beverages, supplements, and beauty products are providing potential growth opportunities to the industry participants, thereby accelerating the regional industry expansion. For instance, in December 2022, Melrose Health Group, an Australian health foods firm, announced plans to expand in China with a new market strategy and new product pipeline, including the launch of a beauty sleep product by combining hyaluronic acid, melatonin, and astaxanthin.